A Shared-Value Model for Enhancing Diabetes Care in South Africa

By Rene Pretorius

April 4, 2025

diabetes care South Africa

Summary

In a world where diabetes management demands both innovation and integration, DiaCision is at the forefront, using AI-driven insights to improve outcomes and reshape the way care is delivered. As we look for transformative models that go beyond traditional approaches, the article “Improving Diabetes Care in South Africa Through a Shared-Value Model” offers an important case study.

This piece reviews a program by Discovery Health, launched in 2021, that aims to enhance diabetes care in South Africa through a shared-value approach. By focusing on improving hemoglobin A1c testing rates, glycemic control, and disease stability, the program has demonstrated measurable success over three years. Notably, it has also contributed to reduced hospital admissions and healthcare costs. In the broader context of advancing diabetes care, this model presents a compelling example of how aligning patient outcomes with system-wide value can lead to scalable, sustainable impact.

Key Insights

  • Shared-Value Model: The program incentivizes medical practitioners to improve diabetes care, leading to better patient outcomes.
  • Glycemic Control and Stability: HbA1c testing rates, glycemic control, and disease stability improved notably.
  • Economic Benefits: Hospital admissions and healthcare costs decreased, suggesting long-term savings.

Background Context

Diabetes is a major global health challenge. The WHO highlights its rising prevalence and the need for effective management. In South Africa, healthcare access varies. Shared-value programs can help bridge gaps in diabetes care in South Africa. The WHO stresses cost-effective interventions that prioritize patient outcomes, aligning with shared-value models.

Implications

This shared-value model has significant implications:

  • Healthcare Cost Reduction: Better diabetes management reduces admissions and costs.
  • Improved Patient Outcomes: Enhanced glycemic control and stability reduce complications and improve quality of life.
  • Scalability and Adaptability: Such programs can inspire similar initiatives elsewhere, aiding broader healthcare reform.

The content highlights innovative healthcare models’ role in improving patient outcomes. Insights from value-based care discussions suggest these models are key to better health outcomes and cost control. For more details, see the original article here.

Reference url

Recent Posts

health economic security
Health Economic Security as a Pillar for Growth in Central and Eastern Europe

By HEOR Staff Writer

June 12, 2026

Central and Eastern European nations face intensifying demographic pressures, including rapid population aging, shrinking workforces, and heightened security risks that endanger long-term prosperity. In a recent EFPIA statement, health economic security is seen as essential, as targeted healthcar...
gene therapy reimbursement
Gene Therapy Reimbursement Strategies for Vision Restoration

By HEOR Staff Writer

June 12, 2026

Gene therapy reimbursement in the Netherlands has demonstrated clear clinical value since the 2021 conditional access agreement for voretigene neparvovec (Luxturna®). Five years of structured real-world use confirmed that carefully designed protocols successfully selected appropriate patients wit...
medtech market access strategy
Prioritizing a Comprehensive Medtech Market Access Strategy Through Stakeholder Engagement

By João L. Carapinha

June 9, 2026

An effective medtech market access strategy must begin at the concept stage by simultaneously addressing patient needs, clinical workflows, regulatory requirements, and payer expectations rather than defaulting to FDA clearance as the sole priority. Startups that ignore this broader view risk bui...